Compare Sinergi Inti Plastindo Tbk. (ESIP) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sinergi Inti Plastindo Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Sinergi Inti Plastindo Tbk. trades at Rp128 (market cap 142.07B), while Brigit Biofarmaka Teknologi Tbk. trades at Rp246 (market cap 167.37B). The key difference: Brigit Biofarmaka Teknologi Tbk. is the larger of the two by market cap. Which is the better fit depends on your goals.
| ESIP | OBAT | |
|---|---|---|
Market Cap | 142.07B | 167.37B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sinergi Inti Plastindo Tbk.
PT Sinergi Inti Plastindo Tbk (the”Company”) was established based on the notarial deed No.123 dated October 12, 2001 from Dr. Irawan Soerodjo, S.H., M.Si., Notary in Jakarta. PT Tanindo Omega Pasifik is a ultimate parent entity.
Read more on ESIP →About Brigit Biofarmaka Teknologi Tbk.
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →
